CHMP recommends approval for XOANACYL, an oral therapy for use in the following therapeutic areas: Iron deficiency, chronic renal failure and ...
European regulators to review GSK's asthma drug Nucala to treat COPD The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...
The European Medicines Agency provides an interactive map with data from the information system for clinical trials. This is for research purposes. The European Medicines Agency (EMA) has added an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback